1887

Chapter 24 : Hepatitis B and D Viruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Hepatitis B and D Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch24-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch24-2.gif

Abstract:

Hepatitis was first described in the fifth century B.C. The earliest known outbreak of hepatitis occurred in Bremen, Germany, in 1883 among shipyard workers who received a smallpox vaccine stabilized with human serum. In 1950, viral hepatitis was referred to as either infectious hepatitis (hepatitis A) or serum hepatitis (hepatitis B) based on the epidemiologic characteristics of the diseases (1). This terminology was adapted by the World Health Organization (WHO) in 1973.

Citation: Horvat R. 2016. Hepatitis B and D Viruses, p 341-350. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch24
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Worldwide distribution of chronic hepatitis B disease (CDC).

Citation: Horvat R. 2016. Hepatitis B and D Viruses, p 341-350. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch24
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Typical sequence of serologic markers in patients with acute HBV infection with resolution of symptoms typical sequence of serologic markers in patients with HBV infection that progresses to chronicity HBV. HBeAg is variably present in these patients.

Citation: Horvat R. 2016. Hepatitis B and D Viruses, p 341-350. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch24
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819156.ch24
1. Bauer W, and Wyman SM. 1950. Infectious hepatitis, epidemic type. N Engl J Med 242:261264.[PubMed]
2. Liang TJ. 2009. Hepatitis B: the virus and disease. Hepatology 49(Suppl):S13S21.[PubMed]
3. Kuo A, Gish R. 2012. Chronic hepatitis B infection. Clin Liver Dis 16:347369.[PubMed]
4. Dane DS, Cameron CH, Briggs M. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1:695698.[PubMed]
5. Servant-Delmas A, Mercier-Darty M, Ly TD, Wind F, Alloui C, Sureau C, Laperche S. 2012. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples. J Clin Virol 53:338345.[PubMed]
6. Lapiński TW, Pogorzelska J, Flisiak R. 2012. HBV mutations and their clinical significance. Adv Med Sci 57:1822.[PubMed]
7. Liu CJ, Kao JH. 2013. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Semin Liver Dis 33:97102.[PubMed]
8. Lin CL, Kao JH. 2011. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 26(Suppl 1):123130.[PubMed]
9. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS. 2012. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720729.[PubMed]
10. Kajiwara E, Tanaka Y, Ohashi T, Uchimura K, Sadoshima S, Kinjo M, Mizokami M. 2008. Hepatitis B caused by a hepatitis B surface antigen escape mutant. J Gastroenterol 43:243247.[PubMed]
11. Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, Zeng J, Candotti D, Allain JP, Li C. 2011. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 49:17301737.[PubMed]
12. Peters MG. 2009. Special populations with hepatitis B virus infection. Hepatology 49(Suppl):S146S155.[PubMed]
13. Rizzetto M, Ciancio A. 2012. Epidemiology of hepatitis D. Semin Liver Dis 32:211219.[PubMed]
14. Hadziyannis SJ. 1997. Review: hepatitis delta. J Gastroenterol Hepatol 12:289298.[PubMed]
15. McMahon BJ. 2010. Recent advances in managing hepatitis B. F1000 Med Rep 2:11.[PubMed]
16. McMahon BJ. 2010. Natural history of chronic hepatitis B. Clin Liver Dis 14:381396.[PubMed]
17. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34:13291339.[PubMed]
18. Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. 2009. National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology 49(Suppl):S4S12.[PubMed]
19. Shi YH, Shi CH. 2009. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15:30993105.[PubMed]
20. Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS. 2015. Present and future therapies of hepatitis B: from discovery to cure. Hepatology 62:18931908.[PubMed]
21. Sunbul M. 2014. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol 20:54275434.[PubMed]
22. Kwon H, Lok AS. 2011. Hepatitis B therapy. Nat Rev Gastroenterol Hepatol 8:275284.[PubMed]
23. Lavanchy D. 2012. Viral hepatitis: global goals for vaccination. J Clin Virol 55:296302.[PubMed]
24. Uribe LA, O'Brien CG, Wong RJ, Gish RR, Tsai N, Nguyen MH. 2014. Current treatment guidelines for chronic hepatitis B and their applications. J Clin Gastroenterol 48:773783.[PubMed]
25. Caspari G, Gerlich WH. 2007. The serologic markers of hepatitis B virus infection—proper selection and standardized interpretation. Clin Lab 53:335343, 391–400.[PubMed]

Tables

Generic image for table
TABLE 1

Hepatitis B virus markers in different stages of infection and convalescence

Citation: Horvat R. 2016. Hepatitis B and D Viruses, p 341-350. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch24

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error